Buy this BMW and meet motorcycle legend Valentino Rossi at his home and at the track. The BMW M4 CS Edition VR46 is a special edition birthday gift to the nine-time world champ, who is now a factory ...

Learn More CSL Ltd (ASX: CSL) shares are up 0.3% at $261.87 today, shaking off the broader market sell-down. This sees the company with a market cap of almost $127 billion, making it the third ...

A special edition of a special edition–that's one way to describe the 2025 BMW M4 CS Edition VR46. It's based on the M4 CS launched last year but with cosmetic changes to celebrate Valentino Rossi's ...

Share on Facebook (opens in a new tab) Share on Twitter (opens in a new tab) Share on Linkedin (opens in a new tab) Share on email (opens in a new tab) ...

The Batmobile is one of the most iconic items among the many wonderful toys employed by Batman. The name is a bit of a misnomer, however, as the Dark Knight employs many different cars in his war ...

While otherwise robust, CSL half-year results last Wednesday revealed the impact of an “alarming” fall off in influenza vaccination rates, especially in the US. CEO Paul McKenzie attributes the ...

Last November, I strapped into the rear passenger seat of an all-electric, four-door sedan with BMW test driver and 24-hour racer Jens Klingmann behind the wheel. It was a cold day at BMW’s ...

Yes. Yes it is. Honestly, Spin Master might have knocked it out of the park with their Batman Forever Retro Batmobile, in more ways than one. On the surface, it’s screen accurate, looking like ...

CSL Limited (ASX:CSL) shareholders are probably feeling a little disappointed, since its shares fell 4.8% to AU$257 in the week after its latest half-year results. Revenues of US$8.5b were in line ...

CSL has a portfolio that includes treatments for haemophilia and immune deficiencies, and influenza vaccines. Credit: © 2023 CSL, All Rights Reserved. CSL has ...

ASX health stocks fell 3.78% over the past week, while the broader market edged up 0.77% Australia’s biggest health care name CSL weighed on sector with soft H1 FY25 result Shares of merged Chemist ...

CSL shares tumbled 4.95% on the day of its half-year results after revenue, net profits and dividends missed market expectations Behring and Vifor outperformed, while Seqirus underperformed due to ...